Innovotech Inc. (TSXV: IOT) has announced its intention to obtain a stock quotation on the OTCQB Venture Market in the United States, a move designed to increase the company's exposure to American investors and improve the liquidity of its common shares. The OTCQB, operated by OTC Markets, is an over-the-counter venture market that provides a platform for companies to trade alongside their primary exchange listings. In conjunction with this effort, Innovotech will also apply for eligibility with the Depository Trust Company (DTC), which would enable simplified electronic clearing and settlement for U.S. investors.
The OTCQB quotation is expected to operate in parallel with Innovotech's primary listing on the TSX Venture Exchange and will not impose additional material compliance or reporting requirements. As a foreign private issuer, the company will continue to meet its existing disclosure obligations on SEDAR+, which satisfy OTC market requirements under established foreign issuer exemptions, according to the company's press release. To qualify for admission to the OTCQB, companies must meet specific financial standards, maintain current reporting, and undergo an annual verification and management certification process.
Innovotech is a Canadian boutique contract research organization specializing in advanced laboratory services and commercializing proprietary technologies. The company is a leader in biofilm science, providing expertise in antimicrobial testing, pharmaceutical analysis, and industrial laboratory solutions. Its widely used MBEC Assay® kit facilitates high-throughput antimicrobial and antibiotic testing. Innovotech serves clients across multiple sectors, delivering customized research and testing services through its ISO-certified and GMP-accredited laboratories, meeting rigorous standards such as those of the U.S. Food and Drug Administration and Health Canada.
Craig Milne, CEO of Innovotech, stated that the OTCQB quotation will enhance the company's visibility to the investment community, making it more accessible to retail and institutional investors in the United States and increasing liquidity. The company's move comes as part of a broader strategy to expand its investor base and capitalize on growth opportunities. More information about Innovotech is available at https://www.innovotech.ca.
The announcement includes forward-looking statements subject to risks and uncertainties, including regulatory outcomes, currency fluctuations, reliance on a small number of customers, and intellectual property protection. The company undertakes no obligation to update these statements except as required by law. The TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
